JP2026004412A5 - - Google Patents

Info

Publication number
JP2026004412A5
JP2026004412A5 JP2025163286A JP2025163286A JP2026004412A5 JP 2026004412 A5 JP2026004412 A5 JP 2026004412A5 JP 2025163286 A JP2025163286 A JP 2025163286A JP 2025163286 A JP2025163286 A JP 2025163286A JP 2026004412 A5 JP2026004412 A5 JP 2026004412A5
Authority
JP
Japan
Prior art keywords
drawings
invention described
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025163286A
Other languages
English (en)
Japanese (ja)
Other versions
JP2026004412A (ja
Filing date
Publication date
Priority claimed from PCT/JP2019/047956 external-priority patent/WO2021111636A1/ja
Application filed filed Critical
Publication of JP2026004412A publication Critical patent/JP2026004412A/ja
Publication of JP2026004412A5 publication Critical patent/JP2026004412A5/ja
Pending legal-status Critical Current

Links

JP2025163286A 2019-12-06 2025-09-30 抗gdf15抗体 Pending JP2026004412A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
PCT/JP2019/047956 WO2021111636A1 (ja) 2019-12-06 2019-12-06 抗gdf15抗体
JPPCT/JP2019/047956 2019-12-06
PCT/JP2020/045062 WO2021112185A1 (ja) 2019-12-06 2020-12-03 抗gdf15抗体
JP2021562720A JP7810556B2 (ja) 2019-12-06 2020-12-03 抗gdf15抗体

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2021562720A Division JP7810556B2 (ja) 2019-12-06 2020-12-03 抗gdf15抗体

Publications (2)

Publication Number Publication Date
JP2026004412A JP2026004412A (ja) 2026-01-14
JP2026004412A5 true JP2026004412A5 (https=) 2026-03-31

Family

ID=76221180

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021562720A Active JP7810556B2 (ja) 2019-12-06 2020-12-03 抗gdf15抗体
JP2025163286A Pending JP2026004412A (ja) 2019-12-06 2025-09-30 抗gdf15抗体

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2021562720A Active JP7810556B2 (ja) 2019-12-06 2020-12-03 抗gdf15抗体

Country Status (9)

Country Link
US (1) US20230036655A1 (https=)
EP (1) EP4070816A4 (https=)
JP (2) JP7810556B2 (https=)
KR (1) KR20220110522A (https=)
CN (1) CN114746443A (https=)
AU (1) AU2020396341A1 (https=)
CA (1) CA3164041A1 (https=)
TW (1) TW202128751A (https=)
WO (2) WO2021111636A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116444667B (zh) * 2023-06-13 2023-09-01 上海驯鹿生物技术有限公司 一种靶向gdf15的全人源抗体及其应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
US6548640B1 (en) 1986-03-27 2003-04-15 Btg International Limited Altered antibodies
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US5859205A (en) 1989-12-21 1999-01-12 Celltech Limited Humanised antibodies
WO1994004679A1 (en) 1991-06-14 1994-03-03 Genentech, Inc. Method for making humanized antibodies
ES2136092T3 (es) 1991-09-23 1999-11-16 Medical Res Council Procedimientos para la produccion de anticuerpos humanizados.
JP3117662B2 (ja) 1997-08-07 2000-12-18 セキ工業株式会社 パーツ整列装置
US9212221B2 (en) * 2010-03-03 2015-12-15 Detroit R & D, Inc. Form-specific antibodies for NAG-1 (MIC-1, GDF-15), H6D and other TGF-β subfamily and heart disease and cancer diagnoses
HRP20191326T1 (hr) * 2012-09-26 2019-11-01 Univ Wuerzburg J Maximilians Monoklonska antitijela za faktor rasta i diferencijacije 15 (gdf-15)
CA2896076C (en) * 2012-12-21 2022-12-06 Aveo Pharmaceuticals, Inc. Anti-gdf15 antibodies
TW201619200A (zh) * 2014-10-10 2016-06-01 麥迪紐有限責任公司 人類化抗-ox40抗體及其用途
CN108463246B (zh) * 2015-10-02 2025-02-28 尤利乌斯·马克西米利安维尔茨堡大学 使用人生长分化因子15(gdf-15)抑制剂和免疫检查点阻断剂的联合治疗
WO2017189724A1 (en) * 2016-04-27 2017-11-02 Novartis Ag Antibodies against growth differentiation factor 15 and uses thereof
KR20230107309A (ko) * 2020-11-10 2023-07-14 카탈임 게엠베하 항-gdf15 항체 및 암 치료용 투여 용법

Similar Documents

Publication Publication Date Title
JP2022191211A5 (https=)
JP2024059739A5 (https=)
JP2025138632A5 (https=)
JP2020127044A5 (https=)
JP2024023385A5 (https=)
JP2022068302A5 (https=)
JP2024129139A5 (https=)
JP2025138641A5 (https=)
JP2023022224A5 (https=)
JP2024059648A5 (https=)
JP2022060295A5 (https=)
JP2024112817A5 (https=)
JP2025118629A5 (https=)
JP2025084837A5 (https=)
JP2023085551A5 (https=)
JP2026004279A5 (https=)
JP2024063214A5 (https=)
JP2024170456A5 (https=)
JP2025066722A5 (https=)
JPWO2020176672A5 (https=)
JP2025509728A5 (https=)
JP2025081323A5 (https=)
JPWO2020252375A5 (https=)
JP2026004412A5 (https=)
JPWO2019222339A5 (https=)